This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read BioRestorative Therapies’s 8K filing here.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc engages in the development of therapeutic products and medical therapies using cell and tissue protocols. Its programs provide quality of care for chronic back pain caused by disc degeneration and metabolic disorders, including obesity and diabetes. The company’s initial investigational therapeutic product being called BRTX-100 focuses on treating damage by an autologous stem cell product that uses own stem cells that are harvested, cultured, and then injected directly into the affected disc to start the repair process.
Further Reading
- Five stocks we like better than BioRestorative Therapies
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- These Stocks Missed on Earnings, But Will Rebound Next Quarter
- Compound Interest and Why It Matters When Investing
- With Policy Shifts in Play, Are Crypto Stocks Worth Another Look?
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Waste Management Stock Is a Top Defensive Play Now
